Requests that the FDA refrain from authorizing the Proposal and (b) disclose the final list of drugs to be imported and any amendments to the Proposal for public comment | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2023-P-1773

Requests that the FDA refrain from authorizing the Proposal and (b) disclose the final list of drugs to be imported and any amendments to the Proposal for public comment

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensMay 4, 2023

Documents

Type	Title	Posted	Comments	Status
Other	Response Letter	Jun 29, 2026	--

Comment Statistics

Total Comments

Keywords

CDER

Citizen Petition

Council for Affordable Health Coverage

Sidley Austin LLP,

Partnership for Safe Medicines

Ballard Spahr LLP

Pharmaceutical Research

Manufacturers of America (“PhRMA”),

Data from Regulations.gov